Provided by Tiger Fintech (Singapore) Pte. Ltd.

Lyra Therapeutics

0.1083
-0.0032-2.87%
Post-market: 0.11290.0046+4.25%19:55 EDT
Volume:1.41M
Turnover:157.22K
Market Cap:7.13M
PE:-0.08
High:0.1150
Open:0.1127
Low:0.1074
Close:0.1115
Loading ...
Nov 07, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Sep 13, 2023

Major Issues Report

Form 8-K - Current report
Sep 01, 2023

Major Issues Report

Form 8-K - Current report
Aug 26, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 08, 2023

Major Issues Report

Form 8-K - Current report
Aug 08, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 15, 2023

Major Issues Report

Form 8-K - Current report
Jul 06, 2023

Correspondence

Form CORRESP - Correspondence
Jun 16, 2023

Major Issues Report

Form 8-K - Current report
Jun 13, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 09, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 02, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 01, 2023

Major Issues Report

Form 8-K - Current report
May 12, 2023

Major Issues Report

8-K - Current report
May 12, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 29, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 29, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Mar 29, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals